Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1132 result(s) found, displaying 676 to 700

  • AusPAR: Ibrutinib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ibrutinib

  • AusPAR: Enzalutamide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for enzalutamide

  • AusPAR: Bortezomib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Bortezomib

  • AusPAR: Lipegfilgrastim (rbe)

    Australian public assessment report (AusPar)
    Australian public assessment report for Lipegfilgrastim (rbe)

  • AusPAR: Nintedanib esilate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Nintedanib esilate

  • AusPAR: Budesonide

    Australian public assessment report (AusPar)
    Australian public assessment report for Budesonide

  • AusPAR: Lenalidomide

    Australian public assessment report (AusPar)
    Australian public assessment report for Lenalidomide

  • AusPAR: Dabigatran etexilate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Dabigatran etexilate

  • AusPAR: Valganciclovir

    Australian public assessment report (AusPar)
    Australian public assessment report for Valganciclovir

  • AusPAR: Ivermectin

    Australian public assessment report (AusPar)
    AusPAR: Ivermectin

  • AusPAR: Nepafenac

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Nepafenac

  • AusPAR: Arsenic trioxide

    Australian public assessment report (AusPar)
    Australian public assessment report for Arsenic trioxide

  • AusPAR: Adalimumab (rch)

    Australian public assessment report (AusPar)
    Australian public assessment report for Adalimumab (rch)

  • AusPAR: Asunaprevir

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Asunaprevir

  • AusPAR: Rifaximin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Rifaximin

  • AusPAR: Anakinra

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Anakinra

  • AusPAR: Apixaban

    Australian public assessment report (AusPar)
    Australian public assessment report for Apixaban

  • AusPAR: Regorafenib

    Australian public assessment report (AusPar)
    Australian public assessment report for Regorafenib

  • AusPAR: Certolizumab pegol (rbe)

    Australian public assessment report (AusPar)
    Australian public assessment report for Certolizumab pegol (rbe)

  • AusPAR: Apremilast

    Australian public assessment report (AusPar)
    Australian public assessment report for Apremilast